Bernhard G. Baumgartner
Vocklabruck, 4840, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Real-World Treatment Patterns and Timeliness of Clinical Care Pathway for Non-Small Cell Lung Cancer Patients in Austria: The PRATER Retrospective Study.
Journal: Cancers
Published: June 11, 2024
AI-powered evaluation of lung function for diagnosis of interstitial lung disease.
Journal: Thorax
Published: February 09, 2024
Validation of a next-generation sequencing assay for the detection of EGFR mutations in cell-free circulating tumor DNA.
Journal: Experimental and molecular pathology
Published: August 04, 2021
Masterplan 2025 of the Austrian Society of Pneumology (ASP)-the expected burden and management of respiratory diseases in Austria
Journal: Wiener klinische Wochenschrift
Published: September 29, 2020
Photo-oxidation of Aromatic Hydrocarbons Produces Low-Volatility Organic Compounds.
Journal: Environmental science & technology
Published: June 10, 2020
Results of the Austrian National Lung Cancer Audit.
Journal: Clinical Medicine Insights. Oncology
Published: May 06, 2020
Performance and Usability of Three Systems for Continuous Glucose Monitoring in Direct Comparison.
Journal: Journal of diabetes science and technology
Published: February 08, 2019
Rapid growth of organic aerosol nanoparticles over a wide tropospheric temperature range.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 30, 2018
Multicomponent new particle formation from sulfuric acid, ammonia, and biogenic vapors.
Journal: Science advances
Published: June 20, 2018
Tolerability of inhaled N-chlorotaurine in humans: a double-blind randomized phase I clinical study.
Tolerability of inhaled N-chlorotaurine in humans: a double-blind randomized phase I clinical study.
Journal: Therapeutic advances in respiratory disease
Published: June 03, 2018
Cell-Free Plasma DNA-Guided Treatment With Osimertinib in Patients With Advanced EGFR-Mutated NSCLC.
Cell-Free Plasma DNA-Guided Treatment With Osimertinib in Patients With Advanced EGFR-Mutated NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: July 25, 2017
Management of malignant pleural mesothelioma-part 2: therapeutic approaches : Consensus of the Austrian Mesothelioma Interest Group (AMIG).
Journal: Wiener klinische Wochenschrift
Published: February 05, 2016
Last Updated: 09/26/2026